首页> 美国卫生研究院文献>Results in Pharma Sciences >Surfactants modify the release from tablets made of hydrophobically modified poly (acrylic acid)
【2h】

Surfactants modify the release from tablets made of hydrophobically modified poly (acrylic acid)

机译:表面活性剂可改善由疏水改性的聚(丙烯酸)制成的片剂的释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many novel pharmaceutically active substances are characterized by a high hydrophobicity and a low water solubility, which present challenges for their delivery as drugs. Tablets made from cross-linked hydrophobically modified poly (acrylic acid) (CLHMPAA), commercially available as Pemulen™, have previously shown promising abilities to control the release of hydrophobic model substances. This study further investigates the possibility to use CLHMPAA in tablet formulations using ibuprofen as a model substance. Furthermore, surfactants were added to the dissolution medium in order to simulate the presence of bile salts in the intestine.The release of ibuprofen is strongly affected by the presence of surfactant and/or buffer in the dissolution medium, which affect both the behaviour of CLHMPAA and the swelling of the gel layer that surrounds the disintegrating tablets. Two mechanisms of tablet disintegration were observed under shear, namely conventional dissolution of a soluble tablet matrix and erosion of swollen insoluble gel particles from the tablet. The effects of surfactant in the surrounding medium can be circumvented by addition of surfactant to the tablet. With added surfactant, tablets that may be insusceptible to the differences in bile salt level between fasted or fed states have been produced, thus addressing a central problem in controlled delivery of hydrophobic drugs. In other words CLHMPAA is a potential candidate to be used in tablet formulations for controlled release with poorly soluble drugs.
机译:许多新颖的药物活性物质的特征在于高疏水性和低水溶性,这对它们作为药物的递送提出了挑战。由交联的疏水改性的聚丙烯酸(CLHMPAA)制成的片剂,以Pemulen TM市售,以前已经显示出控制疏水性模型物质释放的有希望的能力。这项研究进一步研究了以布洛芬为模型物质在片剂中使用CLHMPAA的可能性。此外,将表面活性剂添加到溶出介质中以模拟肠道中胆汁盐的存在。布洛芬的释放受到溶出介质中表面活性剂和/或缓冲剂的存在的强烈影响,这会影响CLHMPAA的行为以及围绕崩解片的凝胶层的膨胀。在剪切作用下观察到片剂崩解的两种机制,即可溶性片剂基质的常规溶解和溶胀的不溶性凝胶颗粒从片剂上的侵蚀。表面活性剂在周围介质中的作用可通过向片剂中添加表面活性剂来规避。通过添加表面活性剂,制得了在禁食或进食状态之间胆汁盐水平差异可能不敏感的片剂,从而解决了疏水性药物的受控递送中的中心问题。换句话说,CLHMPAA是用于片剂制剂中与难溶性药物控制释放的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号